Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jan. 30, 2016	Jan. 31, 2015
Cash flows from operating activities:
Net income	$ 164,504	$ 178,757
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	33,209	31,773
Amortization of intangibles	18,347	24,739
Stock-based compensation expense	15,609	20,371
Gains (Losses) on Extinguishment of Debt	(3,290)	0
Excess tax benefit-stock options	(986)	(4,635)
Deferred income taxes	(7,717)	(2,915)
Other non-cash activity	744	3,743
Changes in operating assets and liabilities	(7,295)	(83,180)
Total adjustments	55,201	(10,104)
Net cash provided by operating activities	219,705	168,653
Cash flows from investing activities:
Purchases of short-term available-for-sale investments	(1,632,014)	(1,211,021)
Maturities of short-term available-for-sale investments	1,409,538	701,149
Sales of short-term available-for-sale investments	47,950	583,750
Additions to property, plant and equipment	(23,128)	(23,760)
Payments for acquisitions, net of cash acquired	0	(118)
Increase in other assets	(6,711)	(3,729)
Net cash (used for) provided by investing activities	(204,365)	46,271
Cash flows from financing activities:
Proceeds from (Repayments of) Debt	(378,156)	0
Payments for Derivative Instrument, Financing Activities	(33,430)	0
Proceeds from debt	1,235,331	0
Dividend payments to shareholders	(124,658)	(115,084)
Repurchase of common stock	(131,977)	(59,636)
Proceeds from employee stock plans	6,229	42,793
Changes in other financing activities	(2,544)	(3,988)
Excess tax benefit-stock options	986	4,635
Net cash provided by (used for) financing activities	571,781	(131,280)
Effect of exchange rate changes on cash	(1,032)	(2,675)
Net increase in cash and cash equivalents	586,089	80,969
Cash and cash equivalents at beginning of period	884,353	569,233
Cash and cash equivalents at end of period	$ 1,470,442	$ 650,202